Advanced search
Publication Cover
Postgraduate Medicine Volume 127, 2015 - Issue 5
Submit an article Journal homepage
475
Views
2
CrossRef citations to date
0
Altmetric
CLINICAL FOCUS: Diabetes   Original Research

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in black/African American patients with type 2 diabetes: Pooled analysis from eight Phase III trials

James ThrasherMedical Investigations, Inc., Little Rock, AR, USACorrespondence[email protected]
,
David S. KountzJersey Shore University Medical Center, Neptune, NJ, USA
,
Susanne CroweBoehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
,
Hans-Juergen WoerleBoehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
&
Maximilian von EynattenBoehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
Pages 419-428 | Received 16 Jan 2015, Accepted 05 Mar 2015, Published online: 03 Apr 2015

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

David S. Kountz. (2017) The use of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and hypertension: a focus on African-American populations. Postgraduate Medicine 129:4, pages 421-429.
Read now

Articles from other publishers (1)

Byron J. Hoogwerf, Michele MacKenzie, Whitney Sealls, Jeanine Cordova & Pranav Gandhi. (2020) Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race. Diabetes Therapy 11:7, pages 1527-1536.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.